SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
04-Apr-24 4:50 PM View: | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 11,255 | -- | -- | 10% 113.75K to 125.01K | |
14-Apr-23 4:35 PM View: | Immunovant, Inc. (IMVT) | 12-Apr-23 | Grant | 12,523 | -- | -- | 12% 101.23K to 113.75K | |
25-Nov-22 1:05 PM View: | Eargo, Inc. (EAR) | 22-Nov-22 | Exercise (in-the money or at-the-money) | 71,363 | $0.50 | $35,681.50 | 200% 35.71K to 107.07K | |
19-Aug-22 4:41 PM View: | Immunovant, Inc. (IMVT) | 17-Aug-22 | Grant | 21,059 | -- | -- | 26% 80.17K to 101.23K | |
12-Jan-22 5:00 PM View: | Immunovant, Inc. (IMVT) | 10-Jan-22 | Grant | 21,726 | -- | -- | 37% 58.45K to 80.17K | |
30-Aug-21 9:08 AM View: | Immunovant, Inc. (IMVT) | 27-Aug-21 | Market Purchase | 18,247 | $8.24 | $150,355.00 | 45% 40.2K to 58.45K | 2% |
28-Apr-21 5:14 PM View: | Eargo, Inc. (EAR) | 27-Apr-21 | Market Sale (Planned) | 1,500 | $55.00 | $82,500.00 | (4%) 37.21K to 35.71K | (< 1%) |
23-Mar-21 8:52 AM View: | Immunovant, Inc. (IMVT) | 19-Mar-21 | Grant | 15,500 | -- | -- | 63% 24.7K to 40.2K | |
22-Oct-20 7:29 PM View: | Eargo, Inc. (EAR) | 20-Oct-20 | Conversion | 37,209 | -- | -- | 100% 0 to 37.21K | |
18-May-20 8:42 AM View: | Immunovant, Inc. (IMVT) | 15-May-20 | Grant | 24,700 | -- | -- | 100% 0 to 24.7K |